115 related articles for article (PubMed ID: 17127464)
1. Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.
Hanson J; Gorman J; Reese J; Fraizer G
Front Biosci; 2007 Jan; 12():2279-90. PubMed ID: 17127464
[TBL] [Abstract][Full Text] [Related]
2. Hormone treatment enhances WT1 activation of Renilla luciferase constructs in LNCaP cells.
Hanson J; Reese J; Gorman J; Cash J; Fraizer G
Front Biosci; 2007 Jan; 12():1387-94. PubMed ID: 17127389
[TBL] [Abstract][Full Text] [Related]
3. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G
Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) is suppressed in WT1-transfected LNCaP cells.
Graham K; Li W; Williams BR; Fraizer G
Gene Expr; 2006; 13(1):1-14. PubMed ID: 16572586
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
6. Androgen up-regulates vascular endothelial growth factor expression in prostate cancer cells via an Sp1 binding site.
Eisermann K; Broderick CJ; Bazarov A; Moazam MM; Fraizer GC
Mol Cancer; 2013 Feb; 12():7. PubMed ID: 23369005
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary conservation of zinc finger transcription factor binding sites in promoters of genes co-expressed with WT1 in prostate cancer.
Eisermann K; Tandon S; Bazarov A; Brett A; Fraizer G; Piontkivska H
BMC Genomics; 2008 Jul; 9():337. PubMed ID: 18631392
[TBL] [Abstract][Full Text] [Related]
8. Suppression of prostate tumor cell growth in vivo by WT1, the Wilms' tumor suppressor gene.
Fraizer G; Leahy R; Priyadarshini S; Graham K; Delacerda J; Diaz M
Int J Oncol; 2004 Mar; 24(3):461-71. PubMed ID: 14767530
[TBL] [Abstract][Full Text] [Related]
9. WT1 protein directly regulates expression of vascular endothelial growth factor and is a mediator of tumor response to hypoxia.
McCarty G; Awad O; Loeb DM
J Biol Chem; 2011 Dec; 286(51):43634-43643. PubMed ID: 22030397
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of insulin-like growth factor-I receptor gene expression in prostate cancer cells.
Damon SE; Plymate SR; Carroll JM; Sprenger CC; Dechsukhum C; Ware JL; Roberts CT
Endocrinology; 2001 Jan; 142(1):21-7. PubMed ID: 11145562
[TBL] [Abstract][Full Text] [Related]
11. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of WT1 binding sites within the human vitamin D receptor gene promoter.
Lee TH; Pelletier J
Physiol Genomics; 2001 Dec; 7(2):187-200. PubMed ID: 11773605
[TBL] [Abstract][Full Text] [Related]
13. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
Brett A; Pandey S; Fraizer G
Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
[TBL] [Abstract][Full Text] [Related]
14. Par-4 transcriptionally regulates Bcl-2 through a WT1-binding site on the bcl-2 promoter.
Cheema SK; Mishra SK; Rangnekar VM; Tari AM; Kumar R; Lopez-Berestein G
J Biol Chem; 2003 May; 278(22):19995-20005. PubMed ID: 12644474
[TBL] [Abstract][Full Text] [Related]
15. Regulation of insulin-like growth factor I receptor promoter activity by wild-type and mutant versions of the WT1 tumor suppressor.
Tajinda K; Carroll J; Roberts CT
Endocrinology; 1999 Oct; 140(10):4713-24. PubMed ID: 10499530
[TBL] [Abstract][Full Text] [Related]
16. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1.
Belali T; Wodi C; Clark B; Cheung MK; Craig TJ; Wheway G; Wagner N; Wagner KD; Roberts S; Porazinski S; Ladomery M
Biochim Biophys Acta Gene Regul Mech; 2020 Dec; 1863(12):194642. PubMed ID: 33017668
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
[TBL] [Abstract][Full Text] [Related]
18. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins.
Stoner M; Wormke M; Saville B; Samudio I; Qin C; Abdelrahim M; Safe S
Oncogene; 2004 Feb; 23(5):1052-63. PubMed ID: 14647449
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
